The purpose of this study is to evaluate the long-term safety of up to two gelatin-hydrogel formulation REACT injections given 3 to 6 months apart and delivered percutaneously into same kidney on renal function in participants with chronic kidney disease (CKD).
The purpose of this study is to evaluate the long-term safety of up to two gelatin-hydrogel formulation REACT injections given 3 to 6 months apart and delivered percutaneously into same kidney on renal function in participants with chronic kidney disease (CKD).
A Long-Term Follow-Up Study of Participants Exposed to REACT
-
Boise Kidney & Hypertension Institute, Meridian, Idaho, United States, 83642
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
For general information about clinical research, read Learn About Studies.
30 Years to 80 Years
ALL
No
Prokidney,
Study Director, STUDY_DIRECTOR, Prokidney
2028-03